As healthcare providers hone their strategies for strengthening access to care, improving health outcomes, and satisfying patients, innovative cancer testing and personalized medicine are increasingly at the forefront. Solaris Health, a national healthcare platform, is one such organization that is helping to advance those aims.
Becker’s Hospital Review recently spoke with two clinical leaders at Solaris Health about their decision to bring hereditary cancer testing in-house for its affiliates:
- Deepak Kapoor, MD, Solaris Health chair, chief ecosystem officer and president of Integrated Medical Professionals (IMP), Solaris’ New York Metro Market affiliate; and
- Kathleen Latino, MD, Solaris Health chief medical officer and IMP’s medical director.
Read the article here.
